Final Results

Image Scan Holdings PLC 17 December 2002 For Immediate Release 17 December 2002 IMAGE SCAN HOLDINGS PLC ('Image Scan' or the 'Company') PRELIMINARY RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2002 Image Scan, a leading provider of multi-view, 3D X-ray imaging technologies for the security and industrial inspection markets announces maiden preliminary results for the year ended 30 September 2002. Key Points • Turnover increased to £502,697(2001: £62,447), with over 66% in the security sector • Group loss before tax of £664,607 (2001: £523,592) • Basic and diluted loss per ordinary share at 4.0p (2001: 4.3p) • Gearing down to 12.5% with borrowings reduced to £128,000 (2001: £719,000) • Research and development expenditure up 70% to £118,000 • Worldwide commercial agreement with security systems leader Rapiscan and a number of specialist development and product supply contracts for security inspection to both the British Government and the Transport Security Administration in USA, signed in the year • First commercial industrial systems to end user customers expected in 2003 Commenting on outlook, Nigel Tipple, Chairman of Image Scan said: 'The pace at which sales accelerated over the second half of the last financial year, the quality of the strategic partnerships so far concluded and the extent of growing interest in our technology, lead us to consider the remainder of the financial year will show continued progress. Our key focus for the forthcoming year is convert the high level of interest generated by our technology into tangible sales of product' All Comparisons are for the year ended 30 September 2001. For further information: Nicholas Fox Chief Executive (Today only) 020 7466 5000 (Thereafter) 01664 503 600 Richard Darby/Suzanne Dunne Buchanan Communications 020 7466 5000 Chairman's Statement Introduction I am pleased to present the results of Image Scan Holdings Plc for the financial year ended 30th September 2002. In my statement, I shall give an overview of the year and comment briefly on the results, significant milestones, current trading and the Board's view of the Company's prospects for the remainder of this financial year. Further detail may be found in the Managing Director's Review of Operations and the financial statements immediately following. Financial Results and Accounting Policy Sales for the year were in excess of £500,000, an increase of seven times the previous year's results. Of these increased sales, over 90 percent arose during the second half of the year. The overhead has increased as part of the Company's planned expansion in the second half to £450,000 taking the annual charge to £876,000 (£490,000 for 2001). After adjustment for flotation costs and other, non-recurring items, the normalised overhead was £760,000, representing a 55.1 percent rise. Gearing at the year-end was 12.5 percent, represented by borrowings of £128,000 (£719,000 for 2001). Shareholders' funds rose to over £1 million. The loss per share was 4.0 pence (4.3 pence in 2001). Our accounting policy is to charge research and development (R&D) costs to the profit and loss account during the period in which they arise. This year has seen a 70% increase in R&D costs to £118,000. In accordance with previously stated policy, no dividend will be recommended for the last financial year. The Commercial Backdrop Our expertise lies in the application of innovative image acquisition, interpretation and presentation technologies. In particular, it remains focused on further developing and commercialising its multiple view X-ray imaging techniques, whereby three-dimensional (3-D) information about objects under inspection may be captured and analysed. Commercial applications for the technology include security, from which we derived over 66 percent of sales last year, with the balance principally arising from industrial inspection products. The product technology and its commercialisation in differing applications are discussed at greater length in the Managing Director's Review below. Significant Milestones In April, the Company was admitted to the Alternative Investment Market (AiM) of the London Stock Exchange, following a successful Placing and Open offer which raised over £600,000 after expenses. In total and before costs, almost £1.8 million of additional equity capital was raised in the financial year 2001/2. The flotation on AiM will serve to enhance our sales' and marketing profile, and underpin our stature when conducting commercial negotiations with much larger corporations. Towards the end of the last financial year an agreement was reached with Rapiscan Security Products Limited (Rapiscan), one of the dominant global manufacturers of security screening systems, for the world wide deployment of our innovative 3-D X-ray technology. Following this agreement the company obtained an order in August from a British government agency for a mobile baggage screening system incorporating one of our 3DX-Cameras. In addition development and product supply contracts were concluded with both the British government and the Transport Security Administration (formerly the Federal Aviation Administration) in America. Current Trading We enter the current financial year with an order book to the value of £377,000, and have presently issued quotations to prospective customers in excess of a further £450,000. The Company's 3DX-CameraTM and software, housed in a bespoke Rapiscan chassis, were exhibited at AvSec World 2002 in Rome during the last week of October. This event is one of the leading, annual aviation security exhibitions with an audience including airport operators, regulators, airlines and security professionals from around the world. The high level of interest shown at AvSec in the performance and functionality of the demonstration unit was encouraging. Development work is in hand which will enable us to offer an industrial inspection solution not only using many of the software features of VIXionTM and AXIS-3D(R) but also capable of operating at higher line speeds. This product, designated DEX, is scheduled for launch during the current financial year. Outlook The pace at which sales accelerated over the second half of the last financial year, the quality of the strategic partnerships so far concluded and the extent of interest in our proprietary technology, particularly for security applications, lead my colleagues and me to consider that the remainder of the financial year will show continued progress. We are very pleased with our developing relationship with Rapiscan, which offers us significant worldwide opportunities and an established 'route to market'. It is necessary, however, to bear in mind that, although our security scanning and industrial inspection systems offer our customers many functional and operational benefits they do represent capital expenditure items that often require Board approval. This process can delay order placement but we are remain optimistic of the level of market penetration achievable for 2003. Our key focus is now on converting the high level of interest generated in the technology into product sales. Other Matters You will see from the attached financial statements that the Board has appointed Deloitte & Touche, Nottingham, as auditors to the Group. I should like to thank Pannel Kerr Forster for their past audit services. Conclusion The Year under review was an exciting period, during which many positive developments transpired within the Company. I should like to record the Board's thanks to the enlarged complement of 16 full-time staff for their contributions, and to shareholders for their continuing support. I look forward to reporting further progress after the end of the first half of the current year. Nigel J. Tipple Chairman 16 December 2002 Managing Director's Review of Operations The key figures in the financial results and the milestones passed during 2001/2 are highlighted in the Chairman's Statement. The increased turnover for last year was derived from three sectoral applications of Image Scan's image capture and image processing technology - security, industrial and medical - each of which is discussed below: Security The Company's range of security products is based upon the 3DX-Camera, which provides, real-time 3-D X-ray images for use in the security screening of baggage, packages, freight and cargoes at airports, border crossing points, secure buildings, logistics' centres and elsewhere. Systems deploying the 3DX-Camera and associated software greatly assist screening operatives to assess rapidly the presence or absence of potential threat items within the item under scrutiny. The second half of the financial year began with a substantial order from the Transport Security Administration (TSA) in America for an AXIS-3D(R) baggage screening unit, which was delivered during this period. At the same time, the TSA contracted Image Scan to develop a 3-D version of Threat Image Projection (TIP) software to run on the AXIS-3D(R) system. TIP is a software package designed to aid the training and performance monitoring of security screening operatives, by randomly introducing threat items (guns, knives, plastic explosive) into the images being viewed. The 3-D TIP software will be made available to the TSA for evaluation during the first quarter of 2003. In July, we concluded a manufacturing and sales agreement with Rapiscan Security Products Limited (Rapiscan), a major global manufacturer, and supplier of X-ray security screening equipment. Shortly thereafter, the Company secured its first order under this agreement, to deliver a mobile, vehicle-mounted 3-D X-ray security scanning unit to a department of the British government. In late October Rapiscan exhibited the first AXIS-3D(R) built jointly by ourselves and Rapiscan at IATA's AvSec World 2002 exhibition in Italy. AvSec World is an important trade fair for the aviation security industry, and the AXIS-3D(R) baggage scanner excited considerable interest from attendees. Business Model Our business model for the security market is either to licence the technology or to act as an OEM supplier of key components, rather than to sell completed systems directly to end users. Our recent agreements demonstrates the implementation of this model. Industrial The industrial inspection systems are designed to facilitate real-time, in-line X-ray inspection of components and assemblies, to ensure conformity with the manufacturer's specification, and to detect and signal any divergence from this. Such industrial inspection applications are particularly relevant if a finished assembly contains concealed working parts, and if the component or assembly is safety-critical, e.g., an electronic automotive component or a drug delivery system. In May we signed a memorandum of understanding with Bespak Plc (Bespak) and subsequently obtained a research contract with the support of Bespak to explore the use of our VIXionTM multiple view X-ray imaging system to inspect their pulmonary and nasal drug delivery and dispensing products. For lower resolution applications (up to 0.5mm), we are working on a system incorporating industrialised versions of the 3DX-Cameras presently used in security systems. Discussions with potential end-users have led us to identify a market opportunity for a medium resolution industrial inspection system, which is capable of operating at line speeds higher than hitherto. This product was referred to in the Chairman's Statement; provisionally to be known as DEX, it is currently in development and is due to be launched later this financial year. Business Model In the medium term, the marketing and distribution model for the industrial inspection market is expected to follow the same strategy adopted for the security market. Initially, however, Image Scan will be working directly with end users in order to develop a series of highly credible reference sites. Medical Whilst no contributions from medical applications are anticipated for at least three or four years, progress on the innovative cervical smear testing research project has exceeded expectations, and the first laboratory trials are now scheduled for the second half of 2004. Revenue in the year of £67,000 was derived solely from the completion of a first phase research paper. Business Model The Company's current policy is to ensure that all research on medical applications of its technology are at least self-funding, owing to the long-term nature of the commercial prospects for such research. Research and Development R&D lies at the heart of Image Scan's commercial potential. The Company's strategy is to identify gaps in existing technology in the market place, to which it believes it can find marketable solutions, either through in-house development, or the integration of external IPR which can be licensed into the Company. When considering new R&D programmes the Company will, wherever feasible, seek to minimise both the technical and commercial risk through collaborative research supported with external funding. An example of the practical implementation of this approach is the research contract awarded in May 2002. This contract, with a total value of £198,000, is to investigate further extending the performance of the Company's VIXionTM system, in addition to developing specific design rules which will enable potential customers to design X-ray inspection capability into their products. This research programme draws on in-house expertise in imaging, X-ray source and detector design, in collaboration with specific key skills from research partners at the University of Bath, Pera and Bespak. The Company maintains close working relationships, both formal and informal, with a number of centres of academic excellence in the UK, Canada and the USA. Included among these organisations are the Police Scientific Development Branch, Transport Security Administration, The Nottingham Trent University, University College London, Barts & The London Hospital Trust, University of Bath, University of Bristol, Pera and Manufacturing Materials Ontario. Staff and Directors Ian Johnson was appointed a non-executive director at the end of January. He is one of the country's leading security consultants, and has served on many industry and government bodies. He has been an adviser on security to companies such as British Airways and Associated British Ports. Ray Gibbs joined Image Scan as Finance Director immediately following the admission to AiM. He has helped to reorganise the Company's financial reporting procedures, and his 20 years' experience in practice and industry are proving valuable. Louise George, the financial controller, has taken on the responsibility of Company Secretary, bringing this function in-house. Jan Zandhuis became business development manager with specific responsibility for the industrial inspection market in May. He is a highly experienced manager of innovative technology, having held senior posts in the U.K. and continental Europe. The technical and administrative teams have also been strengthened during the year, and the staff complement is now 16, of whom 12 are technical and 4 in sales or administrative positions. Finances The Company raised a total of almost £1.8 million (before costs) of new equity finance during the year, and we were therefore able to reduce our indebtedness to a more appropriate level. It is clear, however, that the Company's order book, and the consequent amount of work in progress needed to fund our growth, could rise significantly during the remainder of the current financial year. The average lead time between receipt and delivery of order for the capital equipment items we provide is 14 weeks, and requirements may therefore arise for working capital funding. With this is mind, the Company has negotiated an additional overdraft facility of £250,000, which may be drawn down as the need arises. As a result of a number of special one-off contracts we saw the Company's gross profit margins improve in the second half, from 14.9 percent to 47.7 percent as we concentrated on the delivery of these commercial contracts. Conclusion I would like to thank the staff for their support in the year and ongoing commitment to achieving the Group's continued growth and prospects for the future outlined in the Chairman's Statement. Nicholas D. Fox Managing Director 16 December 2002 GROUP PROFIT AND LOSS ACCOUNT Year ended 30 September 2002 2002 2001 £ £ TURNOVER 502,697 62,447 Cost of sales (262,840) (8,982) Gross profit 239,857 53,465 Administrative expenses (875,575) (489,921) OPERATING LOSS (635,718) (436,456) Interest receivable 13,304 8,291 Interest payable (42,193) (95,427) LOSS ON ORDINARY ACTIVITIES BEFORE TAXATION (664,607) (523,592) Taxation 61,748 - LOSS ON ORDINARY ACTIVITIES ATTRIBUTABLE TO SHAREHOLDERS (602,859) (523,592) Dividends - - Loss retained for the year (602,859) (523,592) Pence Pence Earnings per share Basic and diluted loss per share 4.0 4.3 There are no recognised gains or losses other than the loss for the year and the prior year. All amounts relate to continuing operations during each year. CONSOLIDATED BALANCE SHEET 30 September 2002 2002 2001 £ £ FIXED ASSETS Tangible fixed assets 109,050 104,276 Intangible fixed assets 192,460 265,014 301,510 369,290 CURRENT ASSETS Stock and work in progress 69,931 5,012 Debtors 370,220 29,210 Short term investments - deposit account 42,924 413,468 Cash at bank and in hand 535,197 22,512 1,018,272 470,202 CREDITORS: amounts falling due within one year (157,664) (687,110) NET CURRENT ASSETS/(LIABILITIES) 860,608 (216,908) TOTAL ASSETS LESS CURRENT LIABILITIES 1,162,118 152,382 CREDITORS: amounts falling due after more than one year (90,842) (128,204) 1,071,276 24,178 CAPITAL AND RESERVES Called up share capital 162,502 132,011 Share premium account 2,911,118 1,291,652 Profit and loss account as restated (2,002,344) (1,399,485) EQUITY SHAREHOLDERS' FUNDS 1,071,276 24,178 CONSOLIDATED CASH FLOW STATEMENT Year ended 30 September 2002 2002 2001 £ £ Net cash outflow from operating activities (797,227) (456,821) Returns on investments and servicing of finance Interest received 13,304 8,041 Interest payable (42,193) (95,427) (28,889) (87,386) Capital expenditure and financial investment Purchase of tangible fixed assets (74,651) (100,890) Purchase of intangible fixed assets (16,291) 47,976 (90,842) (52,914) Net cash outflow before management of liquid resources (917,058) (597,121) Management of liquid resources Withdrawal/(purchase) of short term deposits 370,544 (413,468) Financing Issue of ordinary share capital 1,649,957 996,178 Bank loans repaid (37,363) (107,363) Other loans (repaid)/advanced (516,840) 98,280 1,095,754 1,093,458 Increase/(decrease) in cash in the year 549,240 (24,494) NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT Year ended 30 September 2002 i) RECONCILIATION OF OPERATING CASH FLOW 2002 2001 £ £ Operating loss (635,718) (436,456) Depreciation 53,893 42,064 Amortisation 17,500 - Grants received - 250 Research and development written off 71,345 (Increase)/decrease in stock (48,934) 27,382 (Increase)/decrease in debtors (279,262) 29,240 Increase/(decrease) in creditors 23,949 (119,301) Net cash flow from operating activities (797,227) (456,821) ii) ANALYSIS OF NET DEBT 2002 Other Cash non-cash 2001 flow charges 2002 £ £ £ £ Cash at bank and in hand 22,512 512,685 - 535,197 Bank overdraft (36,555) 36,555 - - 549,240 Debt due within one year (37,363) 37,363 (37,363) (37,363) Debt due after one year (128,204) - 37,363 (90,841) Loan from Security Change Limited (516,840) 516,840 - - 554,203 Current asset investments 413,468 (370,544) - 42,924 (282,982) 732,899 - 449,917 iii) RECONCILIATION OF NET CASH FLOW TO MOVEMENT IN NET FUNDS/(DEBT) 2002 2001 £ £ Increase/(decrease) in cash in the period 549,240 (24,494) Cash outflow from decrease in debt 554,203 10,083 Cash inflow/(outflow) from decrease/(increase) in liquid (370,544) 413,468 resources Change in net debt resulting from cash flows 732,899 399,057 Net debt at 1 October (282,982) (682,039) Net funds at 30 September 2002 449,917 (282,982) Notes 1. The financial information set out above does not constitute the Company's statutory accounts for the year ended 30 September or 30 September 2002 but is derived from those accounts. Statutory accounts for 2001 have been delivered to the Registrar of Companies, and those for 2002 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain statements under section 237(2) or (3) of the Companies Act 1985. The financial information has been prepared in accordance with the accounting policies adopted for the 2001 accounts, with the additional note on development costs as follows: 'Expenditure on development costs is written off as incurred unless there is a clearly definable project with a recognisable value that will lead to known future revenue against which the costs can be amortised.' 2. The financial statements for the year ended 30 September 2002 will be posted to shareholders in February 2003 and will also be available thereafter at the registered office, Pera Innovation Park, Nottingham Road, Melton Mowbray, Leicestershire, LE13 0PB. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings